Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 16Neoplasms 14Prostatic Neoplasms 10Hematologic Neoplasms 9Colorectal Neoplasms 8Lung Neoplasms 5Hematopoietic and Lymphatic System Neoplasm 5Squamous Cell Carcinoma of Head and Neck 4Anatomic Stage I Breast Cancer AJCC v8 4Triple Negative Breast Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Mouth Neoplasms 3Melanoma 3Malignant Solid Neoplasm 3Leukemia, Myeloid, Acute 3Head and Neck Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Parotid Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Head and Neck Carcinoma 2Glioma 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Carcinoma, Basal Cell 2COVID-19 2

Interventions

Standard of Care 1Sodium Chloride 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiodermatitis × Standard of Care × 90 days × Clear all
NCT07081074 2026-04-15

ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

West China Hospital

Phase NA Recruiting
40 enrolled

Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡